Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,254.32 -23.19 (-0.44%) Dow
38,366.14 -320.18 (-0.83%) Nasdaq
16,724.47 -10.55 (-0.06%) Bitcoin USD
69,436.43 +1,399.18 (+2.06%) CMC Crypto 200
1,489.62 +21.69 (+1.48%)
NVO Jan 2025 62.500 put
| Previous close | 0.3500 |
| Open | 0.3500 |
| Bid | 0.1600 |
| Ask | 0.3700 |
| Strike | 62.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.3500 - 0.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 28 |
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 3 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate
PR NewswireNovo Nordisk launches national Wegovy® campaign, Power of Wegovy®
Novo Nordisk today launched The Power of Wegovy®, a new national campaign. The campaign aims to educate on the clinical data of Wegovy® (semaglutide) 2.4 mg injection and reflect the collective empowerment people living with obesity can feel when they don't have to manage their weight alone.
ZacksNew to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
